As of Jun 06
| +0.0132 / +4.17%|
The 1 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a +3,839.39% increase from the last price of 0.33.
The current consensus among 1 polled investment analysts is to Hold stock in Sorrento Therapeutics Inc. This rating has held steady since May, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.